// App-Quantinova.ai

: Pre-treatment GH levels and number of therapeutic interventions for acromegaly management are predictive of altered MRI bone shape and severity of arthropathy in acromegaly

Researchers

Presenter

  • Nikolaos Kyriakakis

Principal Investigators

  • Michael Bowes

  • Julie Lynch

  • Sarah R Kingsbury

  • Steve M Orme

  • Robert D Murray

  • Philip G Conaghan

Medical Centers

  • Leeds Teaching Hospitals NHS Trust, Department of Microbiology, Leeds, United Kingdom

  • University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom

  • Imorphics, Manchester, United Kingdom

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acromegaly

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A